Skip to main content
PMC home page
Frontiers in Chemistry logoLink to Frontiers in Chemistry
. 2014 Jul 24;2:54. doi: 10.3389/fchem.2014.00054

Bis-indole derivatives with antitumor activity turn out to be specific ligands of human telomeric G-quadruplex

Jussara Amato 1, Nunzia Iaccarino 1, Bruno Pagano 1, Rita Morigi 2, Alessandra Locatelli 2, Alberto Leoni 2, Mirella Rambaldi 2, Pasquale Zizza 3, Annamaria Biroccio 3, Ettore Novellino 1, Antonio Randazzo 1,*
PMCID: PMC4109613  PMID: 25105115

Abstract

Bis-indolinone derivatives having either 2,6-disubstituted pyridine core (1a and 1b) or 1,10-disubstituted phenanthroline core (2a and 2b), already known to have antitumor activity, have been tested as potential G-quadruplex binders. Compounds 2a and 2b are able to selectively stabilize G-quadruplex over duplex DNA, and also to discriminate among different G-quadruplex structures, having a particular affinity for the parallel form of the human telomeric G-quadruplex. Both compounds are also able to induce telomeric DNA damage that may explain the activity of these compounds.

Keywords: G-quadruplex, anticancer activity, telomeric damage, thermal stabilization, phenanthroline derivatives, pyridine derivatives

Introduction

G-quadruplexes (G4) are four-stranded nucleic acid structures that spontaneously form within G-rich sequences of DNA and RNA in the presence of cations (Bochman et al., 2012). The recent unambiguous evidence of G4 formation in living cells has increased the enthusiasm and has propelled numerous investigations in this field (Biffi et al., 2013). Several experiments have located G4-forming sequences in different critical positions of the human genome, mainly at the telomeric and gene promoter level (Bochman et al., 2012). In particular, the telomeric regions at the chromosome ends play a critical role in the regulation of cellular proliferation. They are made up by 2–20 kb of double-stranded TTAGGG repeats and feature a 3′ single-stranded overhang of 50–500 nucleotides (Wright et al., 1997). Parallel to normal cells proliferation, telomeres get gradually shorter, triggering irreversible cellular growth arrest (senescence) (Harley et al., 1990; Price, 1999). A telomere maintenance mechanism is provided by the six-membered protein complex called shelterin and by telomerase. The latter adds copies of the repeated motif to the end of the single-stranded overhang. This enzyme is transcriptionally repressed in most differentiated human somatic cells while being overexpressed in about 85% of cancer cells (Kim, 1997; Shay and Wright, 2005). In the remaining 15% of human tumors, telomere lengthening is obtained by a different mechanism known as alternative lengthening of telomere (ALT) (Fajkus et al., 2005). In both cases, telomeres are maintained to a stable length with consequent senescence circumvention and cellular immortalization. It has been shown that the 3′ G-rich single-stranded overhang of the human telomeric DNA can adopt G4 structures and that the formation of the G-quadruplexes inhibits telomerase activity in vitro (Zahler et al., 1991). Furthermore, it has also been demonstrated that molecules that stabilize telomeric G-quadruplexes increase the inhibition of the telomerase (Sun et al., 1997) and lead to telomeric protein uncapping, which, in turn, leads to the onset of DNA damage responses and cellular apoptosis. This has opened a new drug intervention field in anticancer therapy. Several different classes of ligands that target G4 DNA have been developed (Granzhan et al., 2010; Monchaud et al., 2010; Ohnmacht and Neidle, 2014). A number of these have been identified by our research group and most of them were discovered in order to target the grooves of the G4 structures (Cosconati et al., 2009, 2010, 2012; Pagano et al., 2010; Petraccone et al., 2011; Di Leva et al., 2013). On the other hand, several other research groups have developed molecules characterized by an extended planar aromatic scaffold, which is generally able to stack on the external G-tetrads of the G4. Compounds having a central pyridine (like, for example, pyridostatin and 360A) (Granotier et al., 2005; Rodriguez et al., 2008) or 1,10-phenanthroline (like, for example, PhenDC3, and PhenDC6) moieties (Dhamodharan et al., 2012) belong to this latter group.

Recently, some of us have synthesized and successfully tested very similar molecules as antitumor agents: the bis-indolinone derivatives with the 2,6-disubstituted pyridine core (1a and 1b) as well as the same derivatives with the 1,10-disubstituted phenanthroline core (2a and 2b) (Figure 1) (Andreani et al., 2008, 2010). Interestingly, the structural similarities of these compounds with the mentioned G4 binders inspired us a further investigation in order to evaluate the G4 binding properties of 1a,b and 2a,b, and possibly to propose a potential mode of action of these derivatives capable to explain their antitumor activity. In particular, in this paper we report the results of the binding studies of compounds 1a,b and 2a,b with different G-quadruplex topologies, along with their capability to induce telomeric damage.

Figure 1.

Figure 1

Open in a new tab

Chemical structures. Chemical structures of compounds 1a,b and 2a,b.

Materials and methods

Oligonucleotides

All synthetic oligonucleotides have been purchased by Biomers (Germany), purified employing standard HPLC protocols and checked for their integrity by MALDI mass spectrometry. In particular, the following DNA sequences have been used for the experiments: two different truncations of human telomeric DNA sequence, namely 5′-TAGGGTTAGGGTTAGGGTTAGGG-3′ (tel23) and 5′-TTAGGGTTAGGGTTAGGGTTAGGGTT-3′ (tel26); two sequences from the promoter region of the c-kit oncogene, namely 5′-AGGGAGGGCGCTGGGAGGAGGG-3′ (ckit1) and 5′-CGGGCGGGCGCGAGGGAGGGG-3′ (ckit2); the self-complementary duplex-forming Dickerson dodecamer 5′-CGCGAATTCGCG-3′ (ds12).

Preparation of the sample

G-quadruplexes were prepared in the appropriate buffer (10 mM Li3PO4, 50 mM KCl, pH 7.0 for ckit2; 10 mM Li3PO4, 100 mM KCl, pH 7.0 for all the other oligonucleotides) at 10 μM single strand concentration, unless otherwise stated. The solutions have been annealed by heating at 90°C for 5 min, and gradually cooling to room temperature overnight. The concentration of all oligonucleotides was measured at 260 nm by UV measurement at 90°C using the appropriate molar extinction coefficients. Parallel arrangement of tel23 oligonucleotide was obtained as reported in the literature (Renciuk et al., 2009), by annealing of 10 mM single strand oligonucleotide in 10 mM Li3PO4, 100 mM KCl, pH 7.0. After annealing, the concentrated DNA solution was kept at 4°C for 24 h before dilution. After dilution (necessary for spectroscopic measurements), the concentration of the sample was refined by measuring absorption at 260 nm, using a molar extinction coefficient appropriate for these conditions. To verify that the dilution did not alter the species in solution, CD spectral changes with time were checked, without any appreciable change observed over the period of time required to complete the experiments.

Circular dichroism (CD) spectroscopy

CD spectra and CD melting curves of oligonucleotides were recorded on a Jasco J-715 spectropolarimeter equipped with a Jasco PTC-423S Peltier temperature controller. CD spectra were recorded in the wavelength range 230–360 nm at 20°C, with a scan rate of 100 nm/min, a response time of 1 s and a bandwidth of 1 nm. All the spectra were averaged over 3 scans. Buffer baseline was subtracted from each spectrum. The DNA concentration was 10 μM (as single strand) and ligand stock solution was 1.5 mM in DMSO. DNA/ligand mixtures were obtained by adding 4 molar equiv. of ligands (40 μ M). CD melting were performed in the temperature range 20–100°C, at the heating rate of 1°C/min by following changes of the CD signal at the wavelengths of maximum variations upon oligonucleotide folding. The melting temperatures were determined from fit of melting curves using two state transition model implemented in Origin 8.0 program. Each melting experiment was performed at least three times.

Gel electrophoresis

Native gel electrophoresis analysis was carried out on 15% polyacrylamide gel at 5°C, which was run in 1×TB (pH 7.5) buffer supplemented with 50 mM KCl. An oligonucleotide concentration of 50 μM was used for each sample. Various amounts (2–4 equiv) of ligands 1a,b and 2a,b were incubated with DNA at 25°C for 1 h before loading. Prior to loading the mixtures onto the gel, 1 μL of glycerol solution (60% v/v) was added. The total volume loaded in each well was 10 μL.

Molecular docking

The crystal structure of the 23-mer human telomeric G-quadruplex DNA 5′-TAGGGTTAGGGTTAGGGTTAGGG-3′ bound to a tetra-substituted naphthalene diimide ligand (PDB code 3CDM) was used as the target for docking studies (Parkinson et al., 2008). The ligand was removed from the structure to leave empty binding sites. The parallel topology of the structure results in accessible external 5' and 3' planar G-tetrad surfaces, defined as the grid box, being the potential binding sites for the ligands. The size of the box was constrained to 15 × 15 × 15 Å in the x, y, and z dimensions. After optimizing the ligands and assigning partial atomic charges, docking calculations were performed with AutoDock4.0 program using Lamarckian genetic algorithm (Morris et al., 2009). Grid maps were generated for each atom type in the ligand using AutoGrid. An active site box was created with a grid spacing of 0.375 Å. The maximum number of energy evaluations was set to 1.0 × 106, the maximum number of genetic algorithm operations was set to 2.7 × 104, the number of individuals in population was set to 150, the rate of mutation and crossover were set to 0.02 and 0.8, respectively. When searching the conformational and orientational spaces of a ligand with rotatable bonds having full flexibility, the structure of the G-quadruplex was kept rigid. 20 independent dockings were carried out to evaluated different ligand poses.

Cells and culture conditions

BJ fibroblasts expressing hTERT plus SV40 early region (BJ-HELT) were obtained as previously reported (Salvati et al., 2010). The cell line was grown in Dulbecco Modified Eagle Medium (D-MEM, Invitrogen Carlsbad, CA, USA) supplemented with 10% fetal calf serum, 2 mM L-glutamin and antibiotics.

Immunofluorescence

Immunofluorescence (IF) was performed as previously described (Salvati et al., 2007). Briefly, cells were fixed in 2% formaldehyde and permeabilized in PBS plus 0.25% Triton X-100 for 5 min at room temperature. For immunolabeling, cells were incubated with primary antibody for 2 h at room temperature, washed twice in PBS and finally incubated with the secondary antibodies for 1 h. The following antibodies were used: rabbit policlonal anti-TRF1 antibody (Abcam Ltd.; Cambridge UK); mouse monoclonal anti-γH2AX antibody (Upstate, Lake Placid, NY); TRITC-conjugated Goat anti-Rabbit, FITC-conjugated Goat anti Mouse (Jackson Immunoresearch, Suffolk, UK). Nuclei were immunostained with DAPI. Fluorescence signals were recorded by using a Leica DMIRE2 microscope equipped with a Leica DFC 350FX camera and elaborated by Leica FW4000 deconvolution software (Leica, Solms, Germany). For quantitative analysis of γH2AX positivity, 200 cells on triplicate slices were scored. For TIF analysis, a single plane was analyzed and 30 γH2AX-positive cells were scored. Cells with at least 4 co-localizations (γH2AX /TRF1) were considered as TIF-positive.

Statistical analysis

The biological experiments have been repeated three times and the obtained results are presented as means ± standard deviation (SD). Significant changes were assessed by using Student's t-test for unpaired data, and P-values < 0.05 (*) were considered significant.

Results and discussion

Target selection

In order to investigate the G-quadruplex binding properties of compounds 1a,b and 2a,b (Figure 1), a number of G-quadruplex forming sequences were selected for this investigation. In particular, we focused our attention on both telomeric and non-telomeric sequences able to form G-quadruplexes and having different folding topologies.

As far as telomeric DNA is concerned, it is well known that, in the presence of K+, it can fold into a variety of G-quadruplex topologies depending on experimental conditions and length of the sequences (Dai et al., 2008). Since this can have important implications in drug discovery, we selected telomeric DNA truncations and experimental conditions such as to have three different folding topologies, which possess most of the structural features of numerous folding topologies of telomeric DNA. Thus, we considered two different truncations of human telomeric DNA sequence, namely tel23 and tel26 (Material and Methods). Vorlickova and co-workers have demonstrated that a high DNA concentration promotes the G4 parallel folding of human telomeric sequence (Renciuk et al., 2009) and that, although intermolecular species may be formed at high concentrations, the majority of oligonucleotides form intramolecular G4 structures. Thus, we prepared a couple of sample of tel23 that were structured at “low concentration” (10 μM) and “high concentration” (10 mM) conditions, respectively. Particularly, at “low concentration” conditions, tel23 is expected to form the so-called hybrid 1 G4 structure (Figure 2) (hereafter referred to as tel23-h), whereas, at “high concentration” conditions, the tel23 is expected to fold into a G4 parallel structure (hereafter referred to as tel23-p). On the other hand, the sequence tel26 at 10 μM is expected to fold into the hybrid 2 G4 structure (Figure 2). In order to verify that these sequences actually adopt the expected folding, CD experiments were performed. Indeed, CD is a well-established technique for determining the presence and the overall topologies of G4 structures (Masiero et al., 2010; Karsisiotis et al., 2011; Randazzo et al., 2013), although it should be noted that the interpretation of CD spectra requires spectra of well characterized G4 structures for comparison. The tel26 sequence showed a CD spectrum having two positive bands at 290 and 268 nm, and a weak negative band at around 240 nm (Figure S1, Supplementary Material). These data are consistent with a hybrid 2 G4 folding topology. Very similar CD spectrum was obtained for tel23-h, indicating also in this case an antiparallel G4 folding topology (namely hybrid 1) (Figure S1, Supplementary Material). Tel23-p actually adopts a parallel conformation, having positive band around 265 nm and a negative band around 240 nm in the CD spectrum (Figure S1, Supplementary Material).

Figure 2.

Figure 2

Open in a new tab

G-quadruplex folding topologies. Pictorial representations of the parallel, hybrid 1 and 2 folding topologies of human telomeric G-quadruplexes.

As mentioned above, we also took into consideration two non-telomeric sequences (see Materials and Methods) and both of them were analyzed by CD spectroscopy. Particularly, we prepared the promoter DNA sequence ckit1, which exists as a parallel structure (Phan et al., 2007), having a characteristic positive band at 262 nm and a negative band at 240 nm in the CD spectrum (Figure S1, Supplementary Material). The other target G-quadruplex considered is that formed by the ckit2 sequence, that exists in a dimeric parallel-stranded conformation (Kuryavyi et al., 2010) as indicated by a major positive band at 262 nm and a negative band at 240 nm.

Finally, in order to evaluate the selectivity of the ligands for the G4 over the duplex DNA, we used as target also the Dickerson duplex-forming dodecamer (ds12).

Binding analysis

Circular dichroism (CD) studies were performed to explore the potential of the new ligands to alter the native folding topology of the investigated G-quadruplexes, inducing a particular conformation. Thus, the bis-indolinone derivatives with the 2,6-disubstituted pyridine core (1a,b), as well as the derivatives with the 1,10-disubstituted phenanthroline core (2a,b) were synthesized as previously described (Andreani et al., 2008, 2010). Upon addition of an excess of ligands (4 equivalents relative to the DNA), no relevant variations of DNA chiroptical signal were observed for all the analyzed structures (Figure S1, Supplementary Material), thus suggesting an overall conservation of the G4 structures as well as of their architectures. Analogously, the interaction between the ligands and the Dickerson duplex-forming dodecamer (ds12) was also investigated by CD spectroscopy to evaluate their effect on the reference DNA duplex. The CD spectra of ds12 in the absence and in presence of ligands in solution were almost superimposable (Figure S1, Supplementary Material), thus suggesting that the investigated compounds do not alter the duplex structure.

Then, the DNA-stabilizing properties of the compounds were evaluated by measuring the ligand-induced change in the melting temperature (ΔTm) of the various G4-forming sequences as well as of the duplex-forming sequence in CD melting experiments (Giancola and Pagano, 2013). All the thermal denaturations were monitored at the wavelengths of maximum CD intensity. In particular, the melting profiles of the parallel G4 structures were recorded at 264 nm (tel23-p) and 262 nm (ckit1, ckit2), while the thermal denaturations of the hybrid-type G4s were monitored at 289 nm (tel23-h) and 290 nm (tel26) (Figure S2, Supplementary Material). Instead, CD melting curves of ds12 duplex were recorded at 280 nm. Ligands 1a and 1b did not increase significantly the stability of any G4 DNAs as well as of duplex (Table 1). On the other hand, ligands 2a and 2b enhanced the stability of the parallel telomeric G4 tel23-p by 5.5 and 15.5°C, respectively (Figure 3 and Table 1). Very interestingly, the same ligands showed to induce only a slight increase (up to 3.0°C) of thermal stability of all the other investigated G4s and none for the duplex. These results highlight the fact that ligands 2a and 2b not only selectively stabilize G4 over duplex DNA, but also discriminate among different G-quadruplex structures.

Table 1.

Melting temperatures.

Ligands Tm(°C)
ckit1 ckit2 tel23-p tel23-h tel26 ds12
No ligand 70.5 (±0.2) 72.5 (±0.2) 68.5 (±0.3) 64.5 (±0.2) 66.5 (±0.2) 64.0 (±0.3)
1a 71.0 (±0.3) 75.5 (±0.2) 71.5 (±0.2) 64.5 (±0.3) 66.5 (±0.3) 64.5 (±0.2)
1b 71.0 (±0.2) 74.0 (±0.3) 68.5 (±0.3) 64.5 (±0.2) 66.5 (±0.3) 62.5 (±0.2)
2a 71.0 (±0.2) 75.0 (±0.2) 74.0 (±0.3) 65.0 (±0.2) 66.5 (±0.3) 64.5 (±0.3)
2b 72.0 (±0.3) 75.0 (±0.3) 84.0 (±0.3) 64.5 (±0.3) 66.5 (±0.2) 64.5 (±0.2)
Open in a new tab

Melting temperatures of G-quadruplex and duplex DNAs with and without ligands measured by CD melting experiments.

Figure 3.

Figure 3

Open in a new tab

CD melting experiments. Normalized CD melting curves of tel23-p in the absence (solid) and in presence of 4 molar equiv of ligands 1a (dash), 1b (dot), 2a (dash dot), and 2b (dash dot dot). Tm values are listed in Table 1.

Nondenaturing gel electrophoresis experiments were performed on tel23-p, that is the G-quadruplex more stabilized by the ligands. In particular, the experiments were performed before and after the addition of the ligands, to confirm the presence of the intramolecular G4 structure as major conformation in solution. As shown in Figure 4, tel23-p moves essentially as single band in the gel, thus suggesting the absence of high-order structures. Moreover, the addiction of ligands did not have any pronounced effect on the G4 mobility. This clearly indicates that (i) all investigated ligands do not induce DNA dimerization/oligomerization, (ii) in agreement with CD results these ligands do not promote any G4 conformational change.

Figure 4.

Figure 4

Open in a new tab

Nondenaturing PAGE. Nondenaturing PAGE of human telomeric DNA tel23-p (50 μM) with increasing equivalents of ligands (2 and 4 eq.) at 5°C. Lanes 1 and 2: bromophenol blue; lane 3: tel23-p alone; lane 4: [tel23-p+1a] 1:2 mixture; lane 5: [tel23-p+1a] 1:4 mixture; lane 6: [tel23-p+1b] 1:2 mixture; lane 7: [tel23-p+1b] 1:4 mixture; lane 8: [tel23-p+2a] 1:2 mixture; lane 9: [tel23-p+2a] 1:4 mixture; lane 10: [tel23-p+2b] 1:2 mixture; lane 11: [tel23-p+2b] 1:4 mixture; lane 12: bromophenol blue.

Biological and molecular activity

The two molecules that were able to significantly increase the thermal stability of the telomeric G4 were further investigated from biological point of view. In particular, we evaluated if the mechanism through which the two bis-indole derivatives 2a and 2b exert their antitumor activity is due to their ability to bind the G4 DNA structures. Thus, human transformed fibroblasts (BJ-EHLT) were exposed for 24 h to different concentrations of the two compounds and activation of DNA damage response (DDR) was evaluated by immunofluorescence. As shown in Figure 5, both ligands, even if at different extents, induced the phosphorylation of H2AX, a hallmark of DDR at almost all the drug doses tested (Thiriet and Hayes, 2005). Specifically, treatment with compound 2a produced a dose-dependent effect with an induction of γH2AX-positive cells starting from 1 μM (about 30%) and reaching about 70% of positive cells at 5 μM concentration (Figure 5). Interestingly, exposure of BJ-EHLT to 0.5 μM of 2b was already sufficient to induce a potent phosphorylation of H2AX (more than 50% of positive cells), percentage that does not further enhanced with the increase of the dosage (Figure 5). Altogether, these results suggest that the chemical substituents introduced in the tested molecules can determine a different affinity of the two ligands for the target.

Figure 5.

Figure 5

Open in a new tab

Analysis of DNA damage response by bis-indole derivatives 2a and 2b. Transformed BJ-EHLT fibroblasts were grown for 24 h in absence (−) or in presence of the indicated concentrations of compound 2a or 2b. DNA damage response was evaluated by immunofluorescence (IF) analysis by using an anti-γH2AX antibody (green) and DAPI (blue) was used to mark nuclei. (A) Representative images of IF analysis. Images were acquired by using a Leica Deconvolution microscope (magnification 20×). (B) Quantification of γH2AX-positive BJ-EHLT fibroblasto from (A). Histograms show the mean values ± SD of at least three independent experiments. p-values were calculated using the student t-test (*p < 0.05; **p < 0.005).

To evaluate whether γH2AX was phosphorylated in response to dysfunctional telomeres, the most effective drug concentrations of both compounds were tested by double immunofluorescence (IF). The analysis performed by deconvolution microscopy revealed that both compounds induced γH2AX foci that colocalized with TRF1, an effective marker for telomeres, generating the so-called telomere-dysfunction induced foci (TIFs) (Takai et al., 2003) (Figure 6), clearly indicating that the tested compounds caused telomere localized damage. Consistent with these data, results from quantitative analysis revealed that both 2a and 2b significantly increased the percentage of cells with more than four γH2AX/TRF1 colocalizations (Pearson's correlation coefficient ≥0.45), with a mean of about 6 TIFs per nucleus (Figure 6).

Figure 6.

Figure 6

Open in a new tab

Analysis of telomere damage by bis-indole derivatives 2a and 2b. BJ-EHLT fibroblasts were grown in absence (−) or in presence of the bis-indole derivatives 2a and 2b at the reported concentration. Upon 24 h, each sample was processed for IF analysis by using antibodies against γH2AX (green) and TRF1 (red) to mark DNA damage and telomeres, respectively. DAPI staining was used to mark nuclei. (A) Representative IF images acquired by using a Leica Deconvolution microscope (magnification 63×). Enlarged views of TIFs are reported on the right of each picture. (B,C) Quantification of TIF-positive cells (B) and mean of TIFs per nucleus (C) from IF experiments reported in (A). Data are means ± SD of three independent experiments. p-values were calculated using the student t-test (**p < 0.005; ***p < 0.001).

Notably, while at the lowest doses of 2a, the majority of γH2AX spots colocalized with TRF1, at the highest concentrations an important fraction of the damage was not localized at the telomeres. On the contrary, compounds induced both telomeric and not telomeric DNA damage even at low drug doses (0.5 μM concentration). This is in line with recent data in which it has been demonstrated that G-quadruplex structures have been found in the promoters of several genes involved in cancer processes (e.g., c-myc, bcl-2, VEGF) an now visualized in extra-telomeric regions of human cells (Biffi et al., 2013).

Molecular docking

In order to understand the mode of binding and the fit of the best ligands (2a,b) within the tel23-p G-quadruplex structure (the most stabilized G4) we performed molecular docking calculations. Among computational methods, molecular docking is one of the most important techniques, and it has been widely used to predict or to give insight into the interaction between small ligands and biological macromolecules (such as proteins and nucleic acids). As more and more G4 structures have been determined (Neidle, 2009), a number of novel ligands have been discovered using this technique (Cosconati et al., 2009; Alcaro et al., 2012; Pagano et al., 2012). We docked the ligands to an X-ray crystal structure of the parallel 23-mer human telomeric G4 (PDB ID 3CDM) using AutoDock (Morris et al., 2009). For each ligand, the most favorable complex was selected from the docked structures on the basis of the calculated binding energies. As expected, in both cases, the predicted most favorable binding mode was one where the phenanthroline core is parallel to the plane of the terminal G-tetrad, making extensive π –π stacking interactions. Noteworthy, in the case of 2b, we observed that the NH group of one of the indolinone systems is hydrogen bonded to the O4' atom of a deoxyribose ring (Figure 7). On the other hand, 2a does not seem capable of forming this additional interaction, probably because of the different spatial arrangement of the indolinone systems, which seem to be involved in an intramolecular lone pair-π stacking interaction, conferring rigidity to the molecule (Figure S3, Supplementary Material). This could justify the higher ability of 2b to increase the thermal stability of the telomeric G4.

Figure 7.

Figure 7

Open in a new tab

Binding pose of 2b on tel23-p. Side (A) and top-view (B) of the binding pose of 2b on tel23-p obtained by docking calculations. Hydrogen bond between the indolinone moiety and the O4' atom of a deoxyribose ring is depicted with a dashed black line.

Conclusions

We have synthesized two bis-indolinone derivatives with the 2,6-disubstituted pyridine core (1a and 1b) and two other derivatives having a 1,10-disubstituted phenanthroline core (2a and 2b). These compounds have shown interesting antitumor activity, even if their mode of action is unknown. Interestingly, the structural similarities of these molecules with well-known G-quadruplex binders like for example pyridostatin (Granotier et al., 2005; Rodriguez et al., 2008) or PhenDC3 and PhenDC6 (Dhamodharan et al., 2012) suggested us that also these molecules could actually bind G-quadruplexes and this interaction maybe responsible of their antitumor activity. Compounds 2a and 2b actually are the only two compounds able to selectively stabilize G4 over duplex DNA and also to discriminate among different G-quadruplex structures, having a particular affinity for the parallel human telomeric G-quadruplex tel23-p. Docking calculations have indicated potential binding modes for those compounds, providing possible explanations of the different affinities and activities, and therefore laying the basis for the development of new ligands. All together these results represent the proof of concept that 2a and 2b interact and stabilize the G4 structures both in vitro and in cellulo, and therefore that they could be considered as the lead compounds for developing new anticancer drugs.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

This work was supported by the “Italian Association for Cancer Research” (MFAG 11947 and IG 14150).

Supplementary material

The Supplementary Material for this article can be found online at: http://www.frontiersin.org/journal/10.3389/fchem.2014.00054/abstract

Click here for additional data file. (1.6MB, DOCX)

References

  1. Alcaro S., Costa G., Distinto S., Moraca F., Ortuso F., Parrotta L., et al. (2012). The polymorphisms of DNA G-quadruplex investigated by docking experiments with telomestatin enantiomers. Curr. Pharm. Des. 18, 1873–1879 10.2174/138161212799958495 [DOI] [PubMed] [Google Scholar]
  2. Andreani A., Burnelli S., Granaiola M., Leoni A., Locatelli A., Morigi R., et al. (2008). Antitumor activity of bis-indole derivatives. J. Med. Chem. 51, 4563–4570 10.1021/jm800194k [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andreani A., Burnelli S., Granaiola M., Leoni A., Locatelli A., Morigi R., et al. (2010). Antitumor activity and COMPARE analysis of bis-indole derivatives. Bioorg. Med. Chem. 18, 3004–3011 10.1016/j.bmc.2010.03.063 [DOI] [PubMed] [Google Scholar]
  4. Biffi G., Tannahill D., McCafferty J., Balasubramanian S. (2013). Quantitative visualization of DNA G-quadruplex structures in human cells. Nat. Chem. 5, 182–186 10.1038/nchem.1548 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bochman L. N., Paeschke K., Zakian V. A. (2012). DNA secondary structures: stability and function of G-quadruplex structures. Nat. Rev. Gen. 13, 770–780 10.1038/nrg3296 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cosconati S., Marinelli L., Trotta R., Virno A., De Tito S., Romagnoli R., et al. (2010). Structural and conformational requisites in DNA quadruplex groove binding: another piece to the puzzle. J. Am. Chem. Soc. 132, 6425–6433 10.1021/ja1003872 [DOI] [PubMed] [Google Scholar]
  7. Cosconati S., Marinelli L., Trotta R., Virno A., Mayol L., Novellino E., et al. (2009). Tandem application of virtual screening and NMR experiments in the discovery of brand new DNA quadruplex groove binders. J. Am. Chem. Soc. 131, 16336–16337 10.1021/ja9063662 [DOI] [PubMed] [Google Scholar]
  8. Cosconati S., Rizzo A., Trotta R., Pagano B., Iachettini S., De Tito S., et al. (2012). Shooting for selective druglike G-quadruplex binders: evidence for telomeric DNA damage and tumor cell death. J. Med. Chem. 55, 9785–9792 10.1021/jm301019w [DOI] [PubMed] [Google Scholar]
  9. Dai J., Carver M., Yang D. (2008). Polymorphism of human telomeric quadruplex structures. Biochimie 90, 1172–1183 10.1016/j.biochi.2008.02.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dhamodharan V., Harikrishna S., Jagadeeswaran C., Halder K., Pradeepkumar P. I. (2012). Selective G-quadruplex DNA stabilizing agents based on bisquinolinium and bispyridinium derivatives of 1,8-naphthyridine. J. Org. Chem. 77, 229–242 10.1021/jo201816g [DOI] [PubMed] [Google Scholar]
  11. Di Leva F. S., Zizza P., Cingolani C., D'Angelo C., Pagano B., Amato J., et al. (2013). Exploring the chemical space of G-quadruplex binders: discovery of a novel chemotype targeting the human telomeric sequence. J. Med. Chem. 56, 9646–9654 10.1021/jm401185b [DOI] [PubMed] [Google Scholar]
  12. Fajkus J., Sýkorová E., Leitch A. R. (2005). Telomeres in evolution and evolution of telomeres. Chromosome Res. 13, 469–479 10.1007/s10577-005-0997-2 [DOI] [PubMed] [Google Scholar]
  13. Giancola C., Pagano B. (2013). Energetics of ligand binding to G-quadruplexes. Top Curr. Chem. 330, 211–242 10.1007/128_2012_347 [DOI] [PubMed] [Google Scholar]
  14. Granotier C., Pennarun G., Riou L., Hoffschir F., Gauthier L. R., De Cian A., et al. (2005). Preferential binding of a G-quadruplex ligand to human chromosome ends. Nucleic Acids Res. 33, 4182–4190 10.1093/nar/gki722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Granzhan A., Monchaud D., Saettel N., Guédin A., Mergny J. L., Teulade-Fichou M. P. (2010). “One ring to bind them all”-Part II: identification of promising G-quadruplex ligands by screening of cyclophane-type macrocycles. J. Nucleic Acids 2010:460561 10.4061/2010/460561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Harley C. B., Futcher A. B., Greider C. W. (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345, 458–460 10.1038/345458a0 [DOI] [PubMed] [Google Scholar]
  17. Karsisiotis A. I., Hessari N. M., Novellino E., Spada G. P., Randazzo A., Webba da Silva M. (2011). Topological characterization of nucleic acid G-quadruplexes by UV absorption and circular dichroism. Angew. Chem. Int. Ed. Engl. 50, 10645–10648 10.1002/anie.201105193 [DOI] [PubMed] [Google Scholar]
  18. Kim N. W. (1997). Clinical implications of telomerase in cancer. Eur. J. Cancer 33, 781–786 10.1016/S0959-8049(97)00057-9 [DOI] [PubMed] [Google Scholar]
  19. Kuryavyi V., Phan A. T., Patel D. J. (2010). Solution structures of all parallel-stranded monomeric and dimeric G-quadruplex scaffolds of the human c-kit2 promoter. Nucleic Acids Res. 38, 6757–6773 10.1093/nar/gkq558 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Masiero S., Trotta R., Pieraccini S., De Tito S., Perone R., Randazzo A., et al. (2010). A non-empirical chromophoric interpretation of CD spectra of DNA G-quadruplex structures. Org. Biomol. Chem. 8, 2683–2692 10.1039/c003428b [DOI] [PubMed] [Google Scholar]
  21. Monchaud D., Granzhan A., Saettel N., Guédin A., Mergny J. L., Teulade-Fichou M. P. (2010). One ring to bind them all”-part I: the efficiency of the macrocyclic scaffold for G-quadruplex DNA recognition. J. Nucleic Acids 2010:525862 10.4061/2010/525862 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Morris G. M., Huey R., Lindstrom W., Sanner M. F., Belew R. K., Goodsell D. S., et al. (2009). AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785–2791 10.1002/jcc.21256 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Neidle S. (2009). The structures of quadruplex nucleic acids and their drug complexes. Curr. Opin. Struct. Biol. 19, 239–250 10.1016/j.sbi.2009.04.001 [DOI] [PubMed] [Google Scholar]
  24. Ohnmacht S. A., Neidle S. (2014). Small-molecule quadruplex-targeted drug discovery. Bioorg. Med. Chem. Lett. 24, 2602–2612 10.1016/j.bmcl.2014.04.029 [DOI] [PubMed] [Google Scholar]
  25. Pagano B., Cosconati S., Gabelica V., Petraccone L., De Tito S., Marinelli L., et al. (2012). State-of-the-art methodologies for the discovery and characterization of DNA G-quadruplex binders. Curr. Pharm. Des. 18, 1880–1899 10.2174/138161212799958332 [DOI] [PubMed] [Google Scholar]
  26. Pagano B., Fotticchia I., De Tito S., Mattia C. A., Mayol L., Novellino E., et al. (2010). Selective binding of distamycin a derivative to G-quadruplex structure [d(TGGGGT)]4. J. Nucleic Acids 2010:247137 10.4061/2010/247137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Parkinson G. N., Cuenca F., Neidle S. (2008). Topology conservation and loop flexibility in quadruplex-drug recognition: crystal structures of inter- and intramolecular telomeric DNA quadruplex-drug complexes. J. Mol. Biol. 381, 1145–1156 10.1016/j.jmb.2008.06.022 [DOI] [PubMed] [Google Scholar]
  28. Petraccone L., Fotticchia I., Cummaro A., Pagano B., Ginnari-Satriani L., Haider S., et al. (2011). The triazatruxene derivative azatrux binds to the parallel form of the human telomeric G-quadruplex under molecular crowding conditions: biophysical and molecular modeling studies. Biochimie 93, 1318–1327 10.1016/j.biochi.2011.05.017 [DOI] [PubMed] [Google Scholar]
  29. Phan A. T., Kuryavyi V., Burge S., Neidle S., Patel D. P. (2007). Structure of an unprecedented G-quadruplex scaffold in the human c-kit promoter. J. Am. Chem. Soc. 129, 4386–4392 10.1021/ja068739h [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Price C. M. (1999). Telomeres and telomerase: broad effects on cell growth. Curr. Opin. Genet. Dev. 9, 218–224 10.1016/S0959-437X(99)80032-X [DOI] [PubMed] [Google Scholar]
  31. Randazzo A., Spada G. P., Webba da Silva M. (2013). Circular dichroism of quadruplex structures. Top. Curr. Chem. 330, 67–86 10.1007/128_2012_331 [DOI] [PubMed] [Google Scholar]
  32. Renciuk D., Kejnovska I., Skolakova P., Bednarova K., Motlova J., Vorlickova M. (2009). Arrangements of human telomere DNA quadruplex in physiologically relevant K+ solutions. Nucleic Acids Res. 37, 6625–6634 10.1093/nar/gkp701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rodriguez R., Muller S., Yeoman J. A., Trentesaux C., Riou J.-F., Balasubramanian S. (2008). A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres. J. Am. Chem. Soc. 130, 15758–15759 10.1021/ja805615w [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Salvati E., Leonetti C., Rizzo A., Scarsella M., Mottolese M., Galati R., et al. (2007). Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J. Clin. Invest. 117, 3236–3247 10.1172/JCI32461 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Salvati E., Scarsella M., Porru M., Rizzo A., Iachettini S., Tentori L., et al. (2010). PARP1 activated at telomeres upon G4 stabilization: possible target for telomere-based therapy. Oncogene 29, 6280-6293 10.1038/onc.2010.344 [DOI] [PubMed] [Google Scholar]
  36. Shay J. W., Wright W. E. (2005). Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26, 867–874 10.1093/carcin/bgh296 [DOI] [PubMed] [Google Scholar]
  37. Sun D., Thompson B., Cathers B. E., Salazar M., Kerwin S. M., Trent J. O., et al. (1997). Inhibition of human telomerase by a G-quadruplex-interactive compound. J. Med. Chem. 40, 2113–2116 10.1021/jm970199z [DOI] [PubMed] [Google Scholar]
  38. Takai H., Smogorzewska A., de Lange T. (2003). DNA damage foci at dysfunctional telomeres. Curr. Biol. 13, 1549-1556 10.1016/S0960-9822(03)00542-6 [DOI] [PubMed] [Google Scholar]
  39. Thiriet C., Hayes J. J. (2005). Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair. Mol. Cell 18, 617-622 10.1016/j.molcel.2005.05.008 [DOI] [PubMed] [Google Scholar]
  40. Wright W. E., Tesmer V. M., Huffman K. E., Levene S. D., Shay J. W. (1997). Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev. 11, 2801–2809 10.1101/gad.11.21.2801 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Zahler A. M., Williamson J. R., Cech T. R., Prescott D. M. (1991). Inhibition of telomerase by G-quartet DNA structures. Nature 350, 718–720 10.1038/350718a0 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (1.6MB, DOCX)

Articles from Frontiers in Chemistry are provided here courtesy of Frontiers Media SA

RESOURCES